Robert Atchinson's Net Worth

$2.26 Billion

Estimate Recalculated Mar 1, 2024 08:48PM EST

Who is Robert Atchinson?

Robert Atchinson has an estimated net worth of $2.26 Billion. This is based on reported shares across multiple companies, which include ORBCOMM Inc., HeartWare International, Inc., Royalty Pharma plc, Celanese Corp, SELECT COMFORT CORP, MULESOFT, INC, GCM Grosvenor Inc., Solaris Oilfield Infrastructure, Inc., HUBBELL INC, Protagonist Therapeutics, Inc, Mandalay Digital Group, Inc., PUMA BIOTECHNOLOGY, INC., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., Advaxis, Inc., Nexvet Biopharma plc, AMCI Acquisition Corp., AMAG PHARMACEUTICALS INC., East Resources Acquisition Co, PACIFIC SUNWEAR OF CALIFORNIA INC, Vitae Pharmaceuticals, Inc, SMART BALANCE, INC., FIVE PRIME THERAPEUTICS INC, CARDIOME PHARMA CORP, Targanta Therapeutics Corp., GENEVA ACQUISITION CORP, and ABEONA THERAPEUTICS INC..

SEC CIK

Robert Atchinson's CIK is 0001403404

Past Insider Trading and Trends

2015 was Robert Atchinson's most active year for acquiring shares with 26 total transactions. Robert Atchinson's most active month to acquire stocks was the month of July. 2017 was Robert Atchinson's most active year for disposing of shares, totalling 38 transactions. Robert Atchinson's most active month to dispose stocks was the month of March. 2020 saw Robert Atchinson paying a total of $84,000,000.00 for 46,015,330 shares, this is the most they've acquired in one year. In 2020 Robert Atchinson cashed out on 13,056,561 shares for a total of $333,391,124.70, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ORBCOMM Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.28%
-100.00K
$4.31
-$431,000.00
7.7M
Aug 12
Form 3
0
0
Form 4
-0.85%
-134.00K
$4.02
-$540,273.69
15.68M
Nov 20 - Nov 21
Form 3
0
0
No matching records found

HeartWare International, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.06%
-110.00K
$91.22
-$10,065,072.00
3.48M
Jul 31 - Aug 3
Form 4
-1.50%
-173.27K
$80.68
-$13,982,322.70
11.34M
Apr 17 - Apr 21
Form 4
+2.62%
100K
$76.94
$7,693,992.80
3.91M
Sep 12 - Sep 15
Form 3
0
0
No matching records found

Royalty Pharma plc (RPRX) Snapshot price: $29.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.87%
-7.30M
$43.92
-$320,672,221.00
38.71M
Dec 17 - Dec 18
Form 4
46.02M
$28.00
$84,000,000.00
46.02M
Jun 18
Form 3
0
0
No matching records found

Celanese Corp (CE) Snapshot price: $149.11

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

SELECT COMFORT CORP (SNBR) Snapshot price: $9.545

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.78%
-213.00K
$10.20
-$2,172,600.00
5.42M
Feb 9
Form 4
-5.37%
-319.20K
$10.20
-$3,255,490.00
5.63M
Feb 4 - Feb 8
Form 4
-12.73%
-867.80K
$10.08
-$8,748,310.00
5.95M
Feb 1 - Feb 3
Form 4
-2.85%
-200.00K
$10.42
-$2,083,423.03
6.82M
Jan 27 - Jan 31
Form 4
+2.18%
150K
$7.22
$1,082,754.08
7.01M
Mar 19
Form 4
+1.48%
100K
$4.75
$475,000.00
6.87M
Dec 8
Form 4
+1.52%
200K
$1.88
$380,775.54
13.4M
Jul 28 - Jul 29
Form 3
0
0
No matching records found